Rationale: Staphylococcus aureus is a major pathogen complicating postsurgical care. Objectives: To test the effect of sterile laparotomy (LAP) on pulmonary clearance of S. aureus in a murine model. Methods: Control and LAP mice were infected intranasally with 10 8 cfu of S. aureus. Microbial clearance, pulmonary leukocyte recruitment, and cytokine profiles were compared between the groups. Antibody neutralization or cytokine gene knockout mice were used to evaluate the role of cytokines. Conclusions: Sterile LAP induced temporary deactivation of innate immune responses to pulmonary S. aureus challenge. Impaired microbial clearance was accompanied by altered cytokine expression and suboptimal activation of pulmonary leukocytes. Lack of early IFN-g induction in the infected lungs of LAP animals is a likely mechanism contributing to the observed phenotype.
Staphylococcus aureus is a common cause of both hospital-and community-acquired pneumonia (1, 2) . The predominance of antibiotic-resistant strains in hospital-acquired S. aureus infections and the emergence of multidrug-resistant communityacquired infections result in high mortality and growing medical costs (3) (4) (5) . About 25% of hospital-acquired infections (i.e., 500,000) are caused by staphylococci, resulting in an annual death rate of approximately 90,000 patients (6) (7) (8) .
On the other hand, nasal carriage of S. aureus is common (9) (10) (11) , and a majority of individuals become S. aureus carriers for a period of time, with only a small fraction ever developing clinical symptoms. This indicates that an intact immune system can effectively recognize and control S. aureus; progressive S. aureus infection arises when these protective mechanisms become either temporarily or permanently impaired. It is likely that expanding our knowledge about endogenous mechanisms responsible for control/clearance of S. aureus will aid the development of novel therapeutic strategies for this pathogen. Pulmonary clearance of S. aureus depends, in part, on phagocytic cells, including resident alveolar macrophages (12) , recruited neutrophils (13, 14) , and mononuclear phagocytes (15) ; these cells are capable of ingestion and intracellular killing of S. aureus (12) (13) (14) (15) (16) .
The impaired pulmonary host response and subsequent clinical infections with S. aureus may be associated with many factors, including underlying diseases such as influenza (17, 18) , cystic fibrosis (19, 20) , HIV infection (21) , chemotherapy (22) , diabetes (6) , mechanical ventilation (23) , and old age. Surgical procedures significantly increase the risk of S. aureus infection (24, 25) , and S. aureus is a major pathogen complicating postsurgical care (26, 27) . One of the major causes of postsurgical S. aureus infection is a direct contamination of a surgical wound and/or implantation of S. aureus with medical devices on which S. aureus can form biofilms. In addition to these risk factors, we consider the possibility that surgical intervention may impair host defenses, which could result in an increased susceptibility to S. aureus infection. Surgical intervention is reported to produce numerous changes in the immune system, including changes in trafficking and function of leukocytes (28) (29) (30) . In experimental models, laparotomy (LAP) was shown to cause a decrease in ex vivo phagocytosis of Candida albicans and decreased respiratory burst in peritoneal macrophages (31) . Furthermore, LAP was shown to decrease ex vivo proliferative capacity and release of IL-2 and IL-3 by splenocytes isolated at 2 and 24 hours postsurgery (32) . It has been also demonstrated that LAP can increase mortalities from bacterial infections and promote pulmonary fibrosarcoma metastases in mice (33) . We tested the hypothesis that surgical intervention impairs host resistance to pulmonary S. aureus infection. In this article, we report that sterile LAP alters the innate immune responses during subsequent S. aureus pulmonary challenge, which results in impaired AT A GLANCE COMMENTARY
Scientific Knowledge on the Subject
Little is known about the natural mechanism of host defenses against the major opportunistic pathogen Staphylococcus aureus.
What This Study Adds to the Field
Sterile laparotomy produces temporary deactivation of innate immune responses to pulmonary S. aureus infection. Lack of early IFN-a induction is a likely mechanism for these findings.
clearance of S. aureus. This impairment is not associated with a deficiency in overall recruitment of leukocytes into the lungs but is associated with an altered cytokine profile in the lungs and altered activation status of pulmonary phagocytes. Some of the preliminary results that were part of these studies have been previously reported in the form of an abstract (34) .
METHODS

Cultures of S. aureus
The S. aureus strain (NCTC 8325) S. aureus subsp. aureus Rosenbach was a gift from Dr. J. Iandolo (University of Oklahoma Health Sciences Center). This strain is characterized by expression of cell wall bound protein A (SPA 1 ), fibronectin binding proteins A and B, and hemolysins a, b, g, d. It is novobiocin, fluoroquinolone, quinolone, rifampin, and tetracycline resistant but sensitive to methicillin. S. aureus cultures were grown from frozen stocks to late logarithmic phase (10 h) in tryptic soy broth (Difco, Detroit, MI) at 378C on a shaker. The growth of cultures was confirmed by turbidity measurement at l 5 600 nm. Bacteria were purified by centrifugation at 2,000 rpm at 48C and washed with chilled nonpyrogenic saline (Travenol, Deerfield, IL). Cultures were adjusted to 10 10 microbes/ml in sterile nonpyrogenic saline and kept on ice throughout the duration of infection.
Mice CD-1 outbred mice and IL-13 1/1 (BALB/c) mice from Charles River (Wilmington, MA), and IL-13 2/2 and IL-4/IL-13 2/-mice originally obtained from Dr. A. McKenzie (Medical Research Council, London, UK) and bred at the University of Michigan breeding colony were used for these experiments. These mice were housed under specific pathogenfree conditions in enclosed filter top cages at the University of Michigan Unit for Laboratory Animal Medicine. The mice were handled and maintained using microisolator techniques with daily monitoring by veterinary personnel. All the animal procedures and animal protocols were reviewed and approved by the VA Subcommittee for Animal Studies (IACUC) and by the University Committee on the Use and Care of Animals at the University of Michigan.
Sterile LAP and Infection with S. aureus
For surgery and/or the intranasal instillation, mice were anesthetized by intraperitoneal injection of ketamine/xylazine mix (100/6.8 mg/kg body weight). The operation area (lower left abdomen) was clipped and washed with iodine betadine followed by ethanol. A 1-cm incision through the skin and abdominal muscle layers was made, resulting in brief exposure of the peritoneal cavity. The incision was followed by closure with surgical wound staples. For the infection, anesthetized mice received 5-ml of bacterial suspension in the corner of a nostril followed by 10 ml of saline to wash. After inhalation of the inoculum, inoculation of the second nostril occurred in identical fashion. For IL-13 reconstitution studies, mouse recombinant IL-13 (Peprotech, Rocky Hill, NJ) was reconstituted in nonpyrogenic saline and instilled into the nostril in place of regular saline wash, which was given to the control mice.
Assessment of Microbial Load and Leukocyte Populations
To evaluate microbial burden and pulmonary leukocyte numbers, lungs were excised after mice were killed and washed in phosphate-buffered saline, and leukocytes were isolated using an enzymatic dispersion protocol described previously (35, 36) . Isolated leukocytes were adjusted in cell culture media, and enumerated in 0.04% trypan blue using a hemocytometer. Differential counts were performed in cytospun slides (Shandon Cytospin, Pittsburgh, PA), fixed/stained by a three-step Diff-Quik whole blood stain (Diff-Quik; VWR Scientific Products, Bridgeport, NJ). A total of 200-400 cells were counted for each sample from randomly chosen, high-power microscopic fields. Colony-forming unit assay of digested lungs was performed as described previously to evaluate microbial load (32) .
Collection of Broncheoalveolar Lavage Fluid
After mice were killed, bronchoalveolar lavage (BAL) fluid was obtained as described previously (32) . The recovered fluid (1.4-1.8 ml total) was spun at 1,500 rpm. The supernatant was removed and stored at 2208C for further cytokine/chemokine analysis, whereas the cells were used for flow cytometry.
Monoclonal Antibodies
The following monoclonal antibodies (mAbs) from BD Biosciences (San Jose, CA) were used: 30-F11 (anti-murine CD45, rat IgG2b), M1/ 70 (anti-murine CD11b, rat IgG2b), HL3 (anti-murine CD11c, hamster IgG1), 2.4G2 (anti-murine CD16/CD32 Fc block, rat IgG2b), M3/84 (anti-murine Mac-3, rat IgG1), and RB6-8C5 (anti-murine Ly6G Gr-1, rat IgG2b). mAbs were primarily conjugated with fluorescein isothiocyanate, biotin, or phycoerythrin; biotinylated Abs were visualized using streptavidin-PerCP (BD Pharmingen). Isotype-matched irrelevant control mAbs (BD Pharmingen) were simultaneously tested in all experiments.
Antibody Staining and Flow Cytometric Analysis
Cells from BAL fluid were stained and prepared for flow cytometric analysis. Staining of Fc-g receptors (Fc-gR) and analysis by flow cytometry were performed as described previously (35, 36) . Fc block was used in all stainings except for stainings involving Fc-gR. Mac-3 staining was used to define newly recruited macrophages and Gr-1 staining was used to identify neutrophils and activated macrophages. CD11b and CD11c staining was used as an additional identifier of macrophages, and Fc-gR staining was used as a measure of macrophage activation.
Detection of Cytokine mRNA by Reverse Transcriptase-Polymerase Chain Reaction
Whole lungs were removed and homogenized in TRIzol reagent (Invitrogen, Carlsbad, CA), and RNA was extracted as described previously (32) . One step reverse transcriptase-polymerase chain reaction (RT-PCR), oligonucleotide primer sequences for cyclophilin (housekeeping gene), IFN-g and IL-13, conditions for RT-PCR, and confirmation by Southern blot were performed as described previously (32) .
Cytokine Detection in BAL Fluid
IFN-g, tumor necrosis factor (TNF)-a, IL-10, keratinocyte-derived chemokine (KC), IL-6, macrophage inflammatory protein-2 (MIP-2), and macrophage inflammatory protein-1a (MIP-1a) in BAL fluid were quantified using specific ELISA kits for the respective murine cytokines (BD Biosciences) and analyzed as described previously (32) .
Calculations and Statistics
Data (mean 6 SE) for each experimental group were derived from at least two independent infections and analyzed via t test or one-or twoway analysis of variance, depending on the number of groups. For individual comparisons of multiple groups, post hoc Tukey's test was used to calculate P values. Survival between the groups was compared using Kaplan-Meier survival analysis coupled with a log rank test. Means with P values less than 0.05 were considered statistically significant.
RESULTS
Effect of Sterile LAP on Mouse Survival after S. aureus Infection
Our first goal was to evaluate the impact of extrathoracic surgery on mortality associated with pulmonary S. aureus infection. CD-1 mice were subjected to sterile LAP or anesthesia alone (control), and infected 24 hours later with 10 8 cfu of S. aureus 8325 intranasally. At 24 hours postinfection, no difference in survival was seen between LAP and control mice ( Figure 1 ). However, at 72 hours postinfection, mortality in the LAP group was double that of the control group; 20% mortality was observed in the LAP group at this time point compared with 10% in the infected control group. No mice had died from surgery alone; survival of uninfected LAP animals that received intranasal saline during the time of infection was 100%. Thus, LAP contributed to an increased mortality in mice with pulmonary S. aureus infection.
Effect of LAP on Pulmonary Clearance of S. aureus
To determine if increased mortality from S. aureus pneumonia in LAP mice was caused by decreased clearance of S. aureus from the lungs, we measured pulmonary S. aureus burden at 24, 48, and 72 hours postinfection. Infected LAP mice demonstrated greater lung burden compared with infected control mice on Days 2 and 3 postinfection ( Figure 2 ). In 81% of infected control mice, S. aureus load in the lungs was below the limit of detection at 72 hours. In contrast, nearly half of infected LAP animals had detectable S. aureus in their lungs. Surviving animals in both groups eventually cleared the infection. To determine if LAP resulted in increased dissemination of S. aureus from the lungs into the blood, homogenized spleens were serially diluted and cultured. Dissemination from lung into the blood (spleen) was minimal. Fewer than 5% of animals had cultures positive for S. aureus, and very few bacteria could be detected during the first 48 hours of infection (data not shown). Severe pulmonary hyperemia and fluid collection in the thoracic cavity were found in the animals that died of the infection. Thoracic fluid was either clear or tinted with blood and was heavily infected with S. aureus. Thus, LAP resulted in a temporarily impaired pulmonary clearance of S. aureus, which resulted in uncontrolled growth of S. aureus in the lungs and the development of pulmonary pathology in the subset of infected animals.
Effect of LAP on Leukocyte Recruitment into the S. aureus-infected Lungs
The depletion of neutrophils with anti-Gr-1 antibody resulted in 100% mortality within 48 hours of infection (data not shown). To determine if a defect in pulmonary leukocyte recruitment was responsible for impaired S. aureus clearance post-LAP, we compared the inflammatory cell composition in the lungs of LAP and control animals. Infected and uninfected lungs were dispersed enzymatically and total lung leukocyte and differential cell counts were determined. LAP did not result in deficiency in leukocyte recruitment on Days 1, 2, or 3 postinfection. However, a slight increase in leukocyte recruitment was observed in LAP mice on Day 1 postinfection (data not shown). This increase was no longer present on Days 2 and 3 postinfection. No difference in pulmonary neutrophil ( Figure 3A ) or mononuclear phagocyte recruitment ( Figure 3B ) was seen between infected control and LAP mice.
To determine if pulmonary leukocytes were equally present in the alveolar space, leukocytes were analyzed in BAL fluid using flow cytometry. The number of CD45 1 cells in the airspace was virtually identical for both control and LAP animals at Day 2 postinfection (control: 1.58 6 0.34 3 10 6 cells; LAP: 1.43 6 0.36 3 10 6 cells). Differential cell counts also revealed similar numbers of mononuclear phagocytes (control: 8. Figure 4B ). However, LAP did result in a significant decrease of cells with high surface expression of Fc-gR, suggesting that the phagocytes recruited into the alveolar space of the infected LAP mice were not fully activated ( Figure 4A) .
Thus, impaired pulmonary S. aureus clearance post-LAP was associated with a differential expression of activation markers by pulmonary leukocytes.
Effect of LAP on S. aureus-induced Cytokine Production by Lung Leukocytes
Differential activation of leukocytes in the alveolar compartment could be a result of changes in the cytokine profile that is produced in response to S. aureus infection in the lungs of control and LAP animals. We hypothesized that the rapid clearance in control mice would be associated with robust induction of proinflammatory cytokines (IFN-g and TNF-a), whereas delayed clearance in LAP animals would be associated with a decreased expression of these cytokines and/or increased expression of counterregulatory cytokines (IL-10, IL-4, and IL-13). These cytokines were evaluated in the BAL fluid of infected control and LAP animals. Infection with S. aureus resulted in the robust induction of proinflammatory cytokines in the lungs. Both IFNg and TNF-a were significantly elevated in BAL fluid after infection with S. aureus ( Figure 5 ). LAP alone did not result in an induction of these cytokines in the lungs; however, pulmonary induction of IFN-g was significantly diminished in infected LAP animals at 24 hours postinfection ( Figure 5 ). Interestingly, TNF-a induction in S. aureus-infected lungs was not affected by LAP, indicating that LAP did not result in an overall defect in proinflammatory cytokine production but specifically affected IFN-g induction. We evaluated IL-4 and IL-10, cytokines that have regulatory effects to those of IFN-g and TNF-a. Both IL-4 and IL-10 were induced in response to S. aureus infection; LAP had no effect on BAL levels of these cytokines in either infected or uninfected lungs. Expression of IL-13 was evaluated by RT-PCR, together with the expression of IFN-g, at 24 hours postinfection ( Figure 6 ). Consistent with observations at the protein level, mRNA for IFN-g was strongly induced in the lungs at 24 hours post-S. aureus infection. Furthermore, the expression of IFN-g mRNA in LAP/S. aureus-infected mice was diminished in comparison with S. aureus-infected control mice ( Figure 6 ). In contrast with robust induction of IFN-g, IL-13 mRNA expression was only slightly induced in the lungs of S. aureus-infected control mice. RT-PCR analysis showed very modest induction of IL-13 mRNA in infected control mice ( Figure 6 ). A dramatic increase in IL-13 mRNA transcript was found in the lungs of infected LAP mice. Thus, LAP altered the pulmonary cytokine profile observed in S. aureus infection, such that early induction of IFN-g was decreased and induction of IL-13 was increased.
We subsequently analyzed a group of pulmonary cytokines/ chemokines that are known to be important in recruitment and activation of leukocytes during the innate host defenses in the lungs. There was an initial increase in innate cytokines/chemokines in both infected control and LAP mice at Day 1 postinfection. Significant differences in pulmonary cytokines between LAP and control groups were not observed until Day 2 postinfection. KC, IL-6, and MIP-2 were all significantly lower in the BAL fluid from infected LAP mice at this time; these differences were no longer significant at Day 3 postinfection (Figure 7 ). No significant difference was observed in MIP-1a levels between infected control and LAP mice. Therefore, downstream of impaired IFN-g and enhanced IL-13 induction, LAP resulted in a decrease of KC, IL-6, and MIP-2 production, which is consistent with the impaired clearance of S. aureus from the lungs of LAP mice.
Effect of IFN-g Depletion on S. aureus Clearance from the Infected Lungs
To determine if the altered cytokine response, in particular the absence of an early IFN-g induction, could explain the delayed clearance of S. aureus from the infected lungs post-LAP, we examined the effect of IFN-g depletion on pulmonary S. aureus clearance. Similar to LAP animals, there was no difference in 
Effect of IL-13 on S. aureus Clearance from the Infected Lungs
Because LAP was associated with both increased IL-13 induction and delayed clearance of S. aureus from the lungs of LAP mice, we studied the effect of IL-13 gene deletion on pulmonary clearance of S. aureus. We expected that IL-13 gene deletion would enhance pulmonary clearance of S. aureus, particularly in LAP-infected mice. Interestingly, the deletion of IL-13 did not enhance pulmonary clearance. Furthermore, IL-13 gene deletion resulted in delayed clearance of S. aureus, suggesting that IL-13 has a protective role in pulmonary clearance of S. aureus ( Figure 8B ). The intranasal reconstitution of mouse recombinant IL-13 (5 mg/mouse) resulted in improved clearance ( Figure  8B ), IL-13 2/2 mice after IL-13 reconstitution cleared S. aureus with the same rate as the IL-13 1/1 mice. Thus, IL-13 contributes to clearance of S. aureus from the infected lungs and therefore increased expression of IL-13 in LAP animals was not responsible for the impaired clearance of S. aureus from the lungs of LAP mice.
Effect of IL-4 and IL-13 Gene Deletion on S. aureus Clearance from the Infected Lungs of Control and LAP Animals
During the pulmonary infection with S. aureus, we observed an induction of IL-4 in both infected control and LAP animals, whereas increased induction of IL-13 was observed only in LAP mice. IL-4 and IL-13 share a common signaling receptor subunit and can thus compensate for each other. To determine if combined signaling of IL-4 and IL-13 was involved in the phenotype of infected LAP mice, we tested the effect of LAP and the effect of combined deletion of IL-4 and IL-13 on pulmonary clearance of S. aureus. The combined deletion of IL-4 and IL-13 resulted in a significantly decreased clearance of S. aureus from the infected lungs. A 100-fold difference in pulmonary colony-forming units between IL-4/IL-13 22/22 and IL-4/IL-13 11/11 mice was found at 24 hours (of 7.67 6 0.28 vs.
6.32 6 0.22 log, n 5 4-8, P 5 0.03), and at 48 hours (5.81 6 0.71 vs. 3.62 6 0.40 log, n 5 8, P 5 0.005). Reconstitution of IL-13 reversed the defect in clearance at 24 hours (6.05 6 0.46, n 5 6), but this beneficial effect was no longer seen at 48 hours, suggesting that, in the combined absence of IL-4 and IL-13, reconstitution of IL-13 has a partial effect. Our final experiment tested the combined effect of LAP and IL-4/IL-13 deletion. Wild-type and IL-4/IL13 22/22 mice were infected with S. aureus. The effect of LAP was additive with the effect of cytokine deletion (Figure 9 ), indicating that the effect of LAP was not driven by overexpression of these type 2 cytokines.
DISCUSSION
Our studies demonstrate that LAP can interfere with host responses to pulmonary S. aureus infection. Sterile LAP followed by S. aureus pulmonary challenge results in increased mortality and delayed microbial clearance. Delayed pulmonary clearance is not associated with defective leukocyte recruitment, but it is associated with hallmarks of impaired leukocyte activation and an altered pulmonary cytokine profile. LAP results in decreased early induction of IFN-g and increased expression of IL-13 in response to S. aureus challenge. Subsequently, infected LAP mice demonstrate a premature decline of KC, IL-6, and MIP-2 compared with infected control mice. IFN-g depletion mimics the effect of LAP in terms of decreased clearance of S. aureus on Day 2 postinfection. In contrast, increased IL-13 expression post-LAP has not proven to be a mechanism of decreased S. aureus clearance after LAP.
Our studies document that abdominal surgery has a deleterious effect on pulmonary innate immune response. This defect is not associated with deficiency or delay in the development of the inflammatory response. Recruitment of neutrophils or monocytes into the lungs is not impeded in infected LAP mice. Adequate leukocyte recruitment in concert with impaired clearance suggests that the effector functions of host defense cells in the lungs are not optimal for clearance of S. aureus. These studies provide a mechanistic explanation for the increased risk of S. aureus infections, including pneumonia, reported in surgery patients (24, 25) .
To assess the activation state of recruited cells, we examined the expression of surface receptors in leukocytes obtained by BAL. The analysis was performed on Day 2 postinfection when the first changes in clearance and mortality were observed in infected LAP mice. Expressions of CD11b, CD11c, and Fc-gR were chosen as surrogates of cell activation, whereas Mac-3 expression was chosen as a surrogate of the resting state of macrophages (37, 38) . No difference in expression of CD11b and CD11c was seen when infected LAP and control groups were compared. However, an increase in Mac-3 expression and a decrease in Fc-gR expression were noted in LAP mice compared with control animals at Day 2 postinfection. These findings are compatible with a lowered state of macrophage activation.
We further demonstrate that the cytokine profile of S. aureusinfected lungs in LAP animals differs from control animals. The early burst of IFN-g production observed in control infected mice is significantly reduced in infected LAP mice. This is the first report that abdominal surgery adversely affects the induction of IFN-g in the lungs in response to an infectious agent (39) . Our finding is consistent with a recent report of decreased IFN-g and IL-12 production by peripheral blood leukocytes in cardiac surgery patients (40) . Leukocytes isolated from these patients in the perioperative period had significantly decreased potential to elicit these cytokines in response to staphylococcal enterotoxin B in vitro (40) . Little is known about the role of IFN-g in pulmonary clearance of S. aureus. In murine septic arthritis models, IFN-g supplementation resulted in increased phagocytosis and protection from septicemia (41, 42) . IFN-g also increased killing of S. aureus in the whole blood (43) . On the other hand, IFN-g increased the incidence of septic arthritis (41) and contributed to high mortality in mice that were injected with a lethal dose of S. aureus (44) . In our experiments with the pneumonia model, IFN-g neutralization resulted in transiently decreased pulmonary clearance of S. aureus on Day 2 but not Day 1 postinfection, which mimics the effects of LAP. This suggests that impaired clearance post-LAP is due, in part, to decreased early induction of IFN-g. IFN-g induces upregulation of Fc-gR, and this is consistent with our finding of decreased surface expression of Fc-gR in LAP mice, which could be secondary to decreased IFN-g induction (45) . In aggregate, these findings argue for the direct involvement of IFN-g in leukocyte activation and clearance of S. aureus.
IL-6 is a multifunctional cytokine that is up-regulated downstream of IFN-g signaling (46) . Previous studies have shown that S. aureus infection induces an increase in IL-6 production (47) and that IL-6 induction is associated with protection in bacterial pneumonia models (48, 49) . Induction of IL-6 is observed on Day 1 postinfection in both control and LAP mice. However, IL-6 continues to increase in control mice and declines in LAP mice at Day 2 postinfection. Although decreased ex vivo induction of IL-6 from peritoneal macrophages was reported after LAP (33), our studies are the first to report that LAP may affect in vivo production of IL-6 in a pneumonia model. KC and MIP-2 are murine analogs of IL-8, known to be important in host defense against S. aureus infections (50). Although we observed a robust induction of KC and MIP-2 at Day 1 postinfection in infected control and LAP mice, infected LAP mice exhibited a decreased production of these innate cytokines/chemokines at Day 2 postinfection. The early induction of KC, MIP-2, and MIP-1a was robust in both infected control and LAP mice, which most likely contributed to a similar magnitude of leukocyte recruitment into the alveolar space. In contrast, the premature decline of these chemokines, and in particular the decreased IL-6, could explain delayed microbial clearance and increased mortality of LAP animals at Days 2 and 3 postinfection.
Interestingly, not all of the tested innate cytokines/chemokines are depressed in infected LAP mice; TNF-a, IL-4, IL-10, and MIP-1a levels do not differ significantly from controls. This observation suggests that LAP in conjunction with S. aureus challenge results in alteration of specific innate immunity signaling pathways rather than an overall reduction of all inflammatory parameters. Because a decrease in IFN-g production occurs in infected mice before any other changes in inflammation/clearance parameters, it is likely that early IFN-g signaling triggers subsequent mediators that are responsible for the sustained activation of leukocytes and the clearance of S. aureus in the lungs.
The reduced early IFN-g induction in S. aureus-challenged LAP animals was accompanied by a robust induction of IL-13, which was not observed in the lungs of infected control animals. During innate immune responses, IFN-g plays a role as an important proinflammatory cytokine, whereas IL-13 is a counterregulatory/repair cytokine (51) . The robustly expressed IL-13 in LAP animals was expected to diminish S. aureus clearance; however, there are no published studies regarding the role of IL-13 in host responses to S. aureus. IL-4, which shares a common signaling pathway with IL-13, has been reported to promote septic arthritis in the murine model (52) . During innate immunity, cytokines associated with the adaptive Th2 responses, (IL-4, IL-10, and IL-13) often play an antiinflammatory role due to their ability to down-regulate proinflammatory cytokine production, including IFN-g. Surprisingly, IL-13 deletion did not enhance the clearance of S. aureus, and pulmonary S. aureus clearance was delayed in IL-13 knockout mice. IL-13 reconstitution reversed clearance impairment, demonstrating that IL-13 has a protective effect rather than interfering with the pulmonary clearance of S. aureus. Factors other than IL-13 play an important role in the deactivation of innate immune responses post-LAP. Our studies do not directly address the factors responsible for IL-13 induction in infected lungs of LAP mice, but we believe that IL-13 expression is induced in response to the repair processes after abdominal surgery. It is likely that, in the case of pulmonary infection with S. aureus, the immunostimulatory and immunoregulatory effects of IL-13 (51, 53) add up to an overall protective effect that supports clearance of S. aureus in the absence of IFN-g. Our final experiment analyzed the combined role of IL-4 and IL-13 in S. aureusinfected lungs. In combination, IL-4 and IL-13 are beneficial in the pulmonary clearance process and the presence of these type 2 cytokines lessens the adverse effect of LAP.
In summary, our studies demonstrate that LAP results in increased mortality and delayed pulmonary clearance in a murine model of S. aureus pneumonia. LAP alone does not induce detectable changes in lung cytokine expression; however, after S. aureus infection, induction of pulmonary IFN-g, IL-13, IL-6, KC, and MIP-2 are altered. In addition, macrophages from LAP mice are suboptimally activated as evidenced by decreased FcgR expression and increased Mac-3 expression. We conclude that LAP followed by infection causes a transient deactivation of innate immune responses resulting in decreased microbial clearance, altered cytokine/chemokine expression pattern, and incomplete activation of macrophages.
